Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talia M Mota

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Frontiers in Immunology|October 17, 2019
HTLV-1 as a Model for Virus and Host Coordinated ImmunoeditingTalia M Mota, R Brad Jones
Seminars in Immunology|September 28, 2020
Immunological approaches to HIV cureAdam R Ward, Talia M Mota, R Brad Jones
Retrovirology|June 27, 2012
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmissionTalia M Mota, John M Murray, Rob J Center, et al.
Frontiers in Immunology|August 27, 2019
Have Cells Harboring the HIV Reservoir Been Immunoedited?Szu-Han Huang, Chase D McCann, Talia M Mota, et al.
AIDS Research and Human Retroviruses|September 11, 2018
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral TherapyNathaniel D Bachtel, Greta A Beckerle, Talia M Mota, et al.
Plos One|July 8, 2016
Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In VitroJenny L Anderson, Talia M Mota, Vanessa A Evans, et al.
Retrovirology|May 13, 2018
HIV latency reversing agents act through Tat post translational modificationsGeorges Khoury, Talia M Mota, Shuang Li, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity Zang, Eva M Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity M Zang, Eva M Stevenson, et al.
Plos One|November 20, 2014
Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapyHao K Lu, Lachlan R Gray, Fiona Wightman, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 17, 2019
HTLV-1 as a Model for Virus and Host Coordinated ImmunoeditingTalia M Mota, R Brad Jones
Seminars in Immunology|September 28, 2020
Immunological approaches to HIV cureAdam R Ward, Talia M Mota, R Brad Jones
Retrovirology|June 27, 2012
Application of a case-control study design to investigate genotypic signatures of HIV-1 transmissionTalia M Mota, John M Murray, Rob J Center, et al.
Frontiers in Immunology|August 27, 2019
Have Cells Harboring the HIV Reservoir Been Immunoedited?Szu-Han Huang, Chase D McCann, Talia M Mota, et al.
AIDS Research and Human Retroviruses|September 11, 2018
Short Communication: Expression of Host Restriction Factors by Memory CD4+ T Cells Differs Between Healthy Donors and HIV-1-Infected Individuals with Effective Antiretroviral TherapyNathaniel D Bachtel, Greta A Beckerle, Talia M Mota, et al.
Plos One|July 8, 2016
Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In VitroJenny L Anderson, Talia M Mota, Vanessa A Evans, et al.
Retrovirology|May 13, 2018
HIV latency reversing agents act through Tat post translational modificationsGeorges Khoury, Talia M Mota, Shuang Li, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity Zang, Eva M Stevenson, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2022
Inhibition of major histocompatibility complex-I antigen presentation by sarbecovirus ORF7a proteinsFengwen Zhang, Trinity M Zang, Eva M Stevenson, et al.
Plos One|November 20, 2014
Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapyHao K Lu, Lachlan R Gray, Fiona Wightman, et al.
Pageof 3